CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | Torley Helen President and CEO | Sale | −50,000 | $39.66 | $2.0M | 537,160 |
| 2021-06-07 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 400,000 |
| 2021-05-11 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
| 2021-05-11 | Torley Helen President and CEO | Sale | −8,456 | $42.17 | $357K | 578,704 |
| 2021-05-11 | Torley Helen President and CEO | Sale | −36,522 | $43.05 | $1.6M | 542,182 |
| 2021-05-11 | Torley Helen President and CEO | Sale | −3,956 | $44.11 | $174K | 538,226 |
| 2021-05-11 | Torley Helen President and CEO | Sale | −1,066 | $44.84 | $48K | 537,160 |
| 2021-05-11 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 450,000 |
| 2021-05-05 | Posard Matthew L. Director | Grant or award | +5,230 | 128,983 | ||
| 2021-05-05 | MATSUI CONNIE Director | Grant or award | +5,230 | 213,983 | ||
| 2021-05-05 | Henderson Jeffrey William Director | Grant or award | +5,230 | 52,839 | ||
| 2021-05-05 | Daly James M Director | Grant or award | +5,230 | 26,232 | ||
| 2021-05-05 | Connaughton Bernadette Director | Grant or award | +5,230 | 32,013 | ||
| 2021-05-05 | BIZZARI JEAN-PIERRE Director | Grant or award | +5,230 | 87,544 | ||
| 2021-05-03 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion | +11,311 | $11.29 | $128K | 134,111 |
| 2021-05-03 | LaBarre Michael J. SVP, Chief Technical Officer | Exercise or conversion · Option to Purchase Common Stock | −11,311 | 0 | ||
| 2021-04-14 | Kelley Kenneth J Director | Sale | −5,000 | $45.00 | $225K | 179,833 |
| 2021-04-05 | Torley Helen President and CEO | Exercise or conversion | +50,000 | $14.66 | $733K | 587,160 |
| 2021-04-05 | Torley Helen President and CEO | Sale | −50,000 | $42.55 | $2.1M | 537,160 |
| 2021-04-05 | Torley Helen President and CEO | Exercise or conversion · Option to Purchase Common Stock | −50,000 | $14.66 | $733K | 500,000 |
Page 50 of 59 · 1,177 trades